Drugs of abuse testing is, in some ways, an imperfect science. With new innovations developing within the industry almost annually, best-practices for drug testing have become muddled, varying sharply from lab to lab.
One of the most common effects of an inefficient drug testing process, lengthy incubation times can have a significant negative impact on results, reliability, and ROI.
The opioid epidemic in the United States is nothing short of a crisis.Over 50,000 peopledied from opiate-related drug overdoses in 2016 alone, and rates are on a precipitous rise. Opiate abuse among demographic groups typically insulated from the risk for drug addiction is skyrocketing.
The drug testing landscape is changing. In the United States, illicit drug use has been steadily increasing for over a decade, and the drugs Americans are using are changing, too. It is estimated that nearly 10% of the general population over the age of 12 has used an illicit drug in the past month.